Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
Stanford University National Cancer Institute (NCI) National Institutes of Health (NIH) |
---|---|
Information provided by: | Stanford University |
ClinicalTrials.gov Identifier: | NCT00186147 |
Bone Marrow Grafting for Leukemia and Lymphoma
Condition | Intervention |
---|---|
Leukemia Lymphoma Hematologic Diseases |
Procedure: collection and storage of tissue samples for research |
Study Type: | Observational |
Official Title: | Bone Marrow Grafting for Leukemia and Lymphoma |
Ages Eligible for Study: | up to 70 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:- All hematopoietic cell transplant recipients and donors who agree to participate
 Exclusion Criteria:- Subject does not agree to participate
United States, California | |
Stanford University School of Medicine | Recruiting |
Stanford, California, United States, 94305 | |
Contact: BMT Referrals 650-723-0822 cctoffice@stanford.edu | |
Contact: Cancer Clinical Trials Office (650) 498-7061 | |
Principal Investigator: Robert S Negrin | |
Sub-Investigator: Karl G. Blume | |
Sub-Investigator: Sandra Jeane Horning | |
Sub-Investigator: Laura Johnston | |
Sub-Investigator: Judith Anne Shizuru | |
Principal Investigator: David Miklos |
Principal Investigator: | David Miklos | Stanford University |
Principal Investigator: | Robert S Negrin | Stanford University |
Study ID Numbers: | BMT19, 13358, BMT19, NCT00186147 |
Study First Received: | September 13, 2005 |
Last Updated: | October 3, 2008 |
ClinicalTrials.gov Identifier: | NCT00186147 |
Health Authority: | United States: Institutional Review Board |
Lymphatic Diseases Leukemia Immunoproliferative Disorders |
Hematologic Diseases Lymphoproliferative Disorders Lymphoma |
Neoplasms Neoplasms by Histologic Type Immune System Diseases |